Impact of pretransplant renal failure: When is listing for kidney-liver indicated?

Liver Transplantation

Volumn 11, Issue 11 SUPPL. 2, 2005, Pages

  Davis, Conie L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALCINEURIN INHIBITOR; CHROMIUM DERIVATIVE; EDETIC ACID; INULIN; IOHEXOL; IOTALAMIC ACID I 125; MIDODRINE; OCTREOTIDE; PENTETATE TECHNETIUM TC 99M; PENTOXIFYLLINE; RAPAMYCIN; VASOPRESSIN DERIVATIVE;

ACUTE DISEASE; ARTICLE; GRAFT REJECTION; HEMODYNAMICS; HEPATORENAL SYNDROME; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVER FUNCTION; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; NEPHROTOXICITY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL TECHNIQUE; SURVIVAL; TREATMENT INDICATION; UNITED STATES;

HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVER TRANSPLANTATION; TREATMENT OUTCOME; WAITING LISTS;

EID: 30444446685     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20617     Document Type: Article

References (36)

1. Davis CL, Gonwa TA, Wilkinson AH. Pathophysiology of renal disease associated with liver disorders: Implications for liver transplantation. Liver Transpl 2002;8:91-109.
2. Davis CL, Gonwa TA, Wilkinson AH. Identification of patients best suited for combined liver-kidney transplantation: Part II. Liver Transpl 2002;8:193-211.
3. Jeyarajah DR, Gonwa TA, McBride M, Testa G, Abbasoglu O, Husberg BS, et al. Hepatorenal syndrome: Combined liver kidney transplants versus isolated liver transplant. Transplantation 1997;64:1760-1765.
4. Cardenas A. Hepatorenal syndrome: A dreaded complication of end-stage liver disease. Am J Gastroenterol 2005;100:460-467.
5. Steiner C, Mitzner S. Experiences with MARS liver support therapy in liver failure: Analysis of 176 patients of the International MARS Registry. Liver 2002;22(Suppl 2):20-25.
6. Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, et al. Molecular adsorbent recycling system (MARS): Clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999;23:319-330.
7. Sen S, Davies NA, Mookerjee RP, Cheshire LM, Hodges SJ, Williams R, Jalan R. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: A randomized controlled study. Liver Transpl 2004;10:1109-1119.
8. Mullhaupt B, Kullak-Ublick GA, Ambuhl P, Maggiorini M, Stocker R, Kadry Z, et al. First clinical experience with molecular adsorbent recirculating system (MARS) in six patients with severe acute on chronic liver failure. Liver 2002;22(Suppl 2):59-62.
9. Jouet P, Meyrier JP, Mal F, Callard P, Guettier C, Stordeur D, et al. Transjugular renal biopsy in the treatment of patients with cirrhosis and renal abnormalities. Hepatology 1996124:1143-1147.
10. Sam R, Leehey DJ, Picken MM. Transjugular renal biopsy in patients with liver disease. Am J Kidney Dis 2001;37:1304-1307.
11. Pham PT, Pham PC, Rastogi A, Wilkinson AH. Review article: Current management of renal dysfunction in the cirrhotic patient. Aliment Pharmacol Ther 2005;21:949-961.
12. Fong TL, Bunnapradist S, Jordan SC, Selby RR, Cho YW. Analysis of the United Network for Organ Sharing database comparing renal allografts and patient survival in combined liver-kidney transplantation with the contralateral allografts in kidney alone or kidney-pancreas transplantation. Transplantation 2003;76:348-353.
13. Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: A paired donor kidney analysis. Transplantation 2002;74:1377-1381.
14. Schaubel D, Desmeules M, Mao Y, Jeffery JR, Fenton S. Survival experience among elderly end stage renal disease patients. A controlled comparison of transplantation and dialysis. Transplantation 1995;60:1389-1394.
15. Narayanan Menon KV, Nyberg SL, Harmsen WS, DeSouza NF, Rosen CB, Krom RA, et al. MELD and other factors associated with survival after liver transplantation. Am J Transplant 2004; 4:819-825.
16. Wong LP, Blackley MP, Andreoni KA, Chin H, Falk RJ, Klemmer PJ. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int 2005;68: 362-370.
17. Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jimenez W, Arroyo V, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: Relevance to liver transplantation. Hepatology 2005;41:1282-1289.
18. Caregaro L, Menon F, Angeli P, Amodio P, Merkel C, Bortoluzzi A, et al. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med 1994;154:201-205.
19. Samyn M, Cheeseman P, Bevis L, Taylor R, Samaroo B, Buxton-Thomas M, et al. Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl 2005;11:344-349.
20. Orlando R, Mussap M, Plebani M, Piccoli P, De Martin S, Floreani M, et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 2002;48:850-858.
21. Organ Procurement and Transplantation Network data as of August 19, 2005.
22. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342:605-612.
23. Cecka JM. The OPTN/UNOS Renal Transplant Registry 2003. Clin Transpl 2003:1-12.
24. Desai NM, Mange KC, Crawford MD, Abt PL, Frank AM, Markmann JW, et al. Predicting outcome after liver transplantation: Utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004;77:99-106.
25. Becker T, Nyibata M, Lueck R, Bektas H, Demirci G, Lehner F, et al. Results of combined and sequential liver-kidney transplantation. Liver Transpl 2003;9:1067-1078.
26. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, et al. End stage renal disease (ESRD) following orthotopic liver transplantation (OLTX) utilizing calcineurin based immunotherapy: Risk of development and treatment. Transplantation 2001;72:1934-1939.
27. Molmenti EP, Jain AB, Shapiro R, Scantlebury V, Lee R, Totsuka E, et al. Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection. Transplantation 2001;71:267-271.
28. Singh N, Gayowski T, Ndimbie OK, Nedjar S, Wagener MM, Yu VL. Recurrent hepatitis C virus hepatitis in liver transplant recipients receiving tacrolimus: Association with rejection and increased immunosuppression after transplantation. Surgery 1996;119:452-456.
29. Witzke O, Baumann M, Patschan D, Patschan S, Mitchell A, Treichel U, et al. Which patients benefit from hemodialysis therapy in hepatorenal syndrome? J Gastroenterol Hepatol 2004; 19:1369-1373.
30. Wong F, Pantea L, Sniderman K. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 2004;40:55-64.
31. Moreau R, Lebrec D. Acute renal failure in patients with cirrhosis: Perspectives in the age of MELD. Hepatology 2003;37:233-243.
32. Restuccia T, Ortega R, Guevara M, Gines P, Alessandria C, Ozdogan O, et al. Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. J Hepatol 2004;40:140-146.
33. Skluzacek PA, Szewc RG, Nolan CR 3rd, Riley DJ, Lee S, Pergola PE. Prediction of GFR in liver transplant candidates. Am J Kidney Dis 2003;42:1169-1176.
34. Platt JF, Ellis JH, Rubin JM, Merion RM, Lucey MR. Renal duplex doppler ultrasonography: A noninvasive predictor of kidney dysfunction and hepatorenal failure in liver disease. Hepatology 1994;20:362-369.
35. Kastelan S, Ljubicic N, Kastelan Z, Ostojic R, Uravic M. The role of duplex doppler ultrasonography in the diagnosis of renal dysfunction and hepatorenal syndrome in patients with liver cirrhosis. Hepatogastroenterolgy 2004;51:1408-1412.
36. Al-Kareemy EA, Sobh MA, Muhammad AM, Saber RA. Renal dysfunction in liver cirrhosis: Renal duplex Doppler US vs. scintigraphy for early identification. Clin Radiol 1998;53:44-48.